You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IgA

Showing 1 - 25 of 2,376
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary IgA Nephropathy Trial (HRS-5965, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Nov 14, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (BION-1301, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
May 2, 2023

Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • SHR-2010 Injection
  • Placebo
  • (no location specified)
Apr 27, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

Not yet recruiting
  • Glomerulonephritis, IGA
  • Blood collection
  • Urine sample
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Mar 17, 2023

Primary IgA Nephropathy Trial (RO7434656, Placebo)

Not yet recruiting
  • Primary IgA Nephropathy
  • (no location specified)
Mar 22, 2023

IgA Nephropathy Trial in Hangzhou (Telitacicept, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Oct 25, 2022

IgA Selective Deficiency - Clinical Manifestations and Risk of

Recruiting
  • COVID-19
    • Strasbourg, France
      Service d'Immunologie Clinique - Médecine Interne - CHU de Stras
    Nov 7, 2023

    IgA Nephropathy Trial in Shanghai

    Recruiting
    • IgA Nephropathy
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai JiaoTong University School of Medicine
      Nov 1, 2022

      IgA Nephropathy Trial in Shanghai (rituximab group)

      Active, not recruiting
      • IgA Nephropathy
      • rituximab group
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Apr 9, 2023

      Link Between Complement Activation and IgA Nephropathy Severity

      Recruiting
      • IgA Nephropathy Severity in Kidney Transplantation
      • IgAN patients
      • Strasbourg, France
        Service de néphrologie
      Aug 18, 2022

      Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)

      Not yet recruiting
      • Glomerulonephritis, IGA
      • (no location specified)
      Aug 19, 2022

      IgA Nephropathy Trial (CM338)

      Not yet recruiting
      • IgA Nephropathy
      • CM338
      • (no location specified)
      Mar 7, 2023

      Prenatal Antibiotics and Breast Milk / Neonatal IgA

      Not yet recruiting
      • Prenatal Exposure Delayed Effects
      • +4 more
      • (no location specified)
      Apr 2, 2023

      Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

      Not yet recruiting
      • Glomerulonephritis, IGA
      • +4 more
      • Microscopic hyperspectral imaging system
      • (no location specified)
      Mar 31, 2023

      Primary IgA Nephrology Trial in Beijing (Nefecon)

      Not yet recruiting
      • Primary IgA Nephrology
      • Beijing, Beijing, China
        Peking University First Hospital
      Sep 6, 2022

      Anorexia Nervosa, Healthy Volunteer Trial in Saint-Étienne (Stool sample, Food intake evaluation)

      Not yet recruiting
      • Anorexia Nervosa
      • Healthy Volunteer
      • Stool sample
      • Food intake evaluation
      • Saint-Étienne, France
        Chu Saint-Etienne
      Apr 24, 2023

      Celiac Disease Trial in Spain

      Recruiting
      • Celiac Disease
        • Terrassa, Barcelona, Spain
        • +5 more
        Aug 10, 2023

        Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

        Not yet recruiting
        • Diabetic Kidney Disease
        • IgA Nephropathy
        • Placebo of SC0062
        • +3 more
        • (no location specified)
        Jan 9, 2023

        IgA Nephropathy, Focal Segmental Glomerulosclerosis Trial in Nanjing (HS-10390 tablet, Placebo tablet)

        Recruiting
        • IgA Nephropathy
        • Focal Segmental Glomerulosclerosis
        • HS-10390 tablet
        • Placebo tablet
        • Nanjing, Jiangsu, China
          Zhongda Hospital, Affiliated to Southeast University
        Jul 12, 2023

        Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

        Recruiting
        • Bortezomib
        • +5 more
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
        Oct 28, 2022

        Nasopharyngeal Carcinoma Trial in Zhongshan, Wuzhou (Blood and saliva, P85-Ab, EBNA1-IgA, VCA-IgA and EBV DNA, Fiberoptic

        Recruiting
        • Nasopharyngeal Carcinoma
        • Blood and saliva
        • +2 more
        • Zhongshan, Guangdong, China
        • +1 more
        Jul 20, 2022

        IgA Nephropathy Trial in Doral, Kyiv (AVB-S6-500)

        Terminated
        Has Results
        • IgA Nephropathy
        • Doral, Florida
        • +1 more
        Jan 18, 2022

        Simplified Severity Score in Bullous Pemphigoid

        Not yet recruiting
        • Bullous Pemphigoid
        • IGA score
        • BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)
        • Bordeaux, France
        • +10 more
        May 4, 2022

        IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

        Active, not recruiting
        • IgA Nephropathy (IgAN)
        • +2 more
        • Vancouver, British Columbia, Canada
        • +19 more
        Jan 13, 2023